Drug reference
cefprozil
Cephalosporin (Second-Generation) · Antibacterial, β-Lactam Antibiotic, Cell Wall Synthesis Inhibitor (Second-Generation Cephalosporin)
Cephalosporin (Second-Generation)Antibacterial, β-Lactam Antibiotic, Cell Wall Synthesis Inhibitor (Second-Generation Cephalosporin)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
B
FDA category + note
Mechanism
Not yet extracted
Indications
Upper respiratory tract infections (sinusitis, otitis media)BronchitisENT infectionsSkin infectionsStrep. pyogenes, Strep. pneumoniae, Staph. aureus, H. influenzae, Moraxella and Klebsiella (augmented activity)
Pharmacokinetics
Half-life
1.3 hours
Bioavailability
good oral absorption (>90%)
Excretion
by the kidney
Side effects
Common
Gastrointestinal side effects (e.g., diarrhea)
Serious
- Hypersensitivity reactions (rash to anaphylaxis)
- Serum sickness
- Stevens-Johnson syndrome
- Nephropathy
- Hematologic reactions (neutropenia, prolonged use)
- Neurotoxicity (seizure, high doses, renal impairment)
Pregnancy & lactation
Pregnancy
B
Related guidelines
Ask House about cefprozil
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e·Verified: 2026-05-10 · House clinical team